Company Filing History:
Years Active: 2000-2021
Title: The Innovative Contributions of Lawrence Joseph Heinz, II
Introduction
Lawrence Joseph Heinz, II is a notable inventor based in Pittsboro, Indiana, with a remarkable portfolio of 12 patents. His work primarily focuses on pharmaceutical innovations that address critical health issues, particularly in the fields of oncology and metabolic disorders.
Latest Patents
Among his latest patents, Heinz has developed CD73 inhibitors, which include 5-[5]-[2-cycloalkyl]-6-pyridazin-3-yl]-1H-pyrimidine-2,4-dione compounds. These compounds, or their pharmaceutically acceptable salts, inhibit the activity of CD73 and are useful in treating cancer. Another significant invention is related to multicyclic compounds that serve as melanin concentrating hormone antagonists. These compounds are designed for the treatment, prevention, or amelioration of symptoms associated with obesity and related diseases.
Career Highlights
Heinz is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His contributions to the field of medicine through innovative drug development have positioned him as a key figure in the industry.
Collaborations
Heinz has collaborated with notable colleagues, including Jill A Panetta and John Kevin Shadle, enhancing the collaborative spirit of innovation within his workplace.
Conclusion
Lawrence Joseph Heinz, II exemplifies the spirit of innovation through his significant contributions to pharmaceutical inventions. His work continues to impact the treatment of serious health conditions, showcasing the importance of research and development in medicine.